All In Biotech

Drug Trial Radar · NCT00278746

Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting

An Effectiveness Trial Examining the Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting.

Last checked: Nov 19, 2026Latest source record: Jun 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 20,032 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

20,032

Actual

Start

Jan 2005

Primary completion

Sep 2006

Study completion Sep 2006

Sponsor

Lead sponsor
Society for Applied StudiesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ministry of Science and Technology, India; United Nations Children's Fund, Delhi; World Health Organization
First posted
Jan 18, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 month, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Several studies have shown the beneficial effect of zinc treatment in acute diarrhea. There was a significant reduction in duration of the treated episodes and in their severity as measured by diarrheal stool output or frequency. Zinc is a potentially important immunomodulator or nutraceutical which may have great impact as therapeutic agent in conditions like diarrhea and pneumonia. The issue is whether and how zinc should be introduced in primary health care programs for treatment of acute diarrhea. A practical, sustainable intervention for introduction of zinc as treatment of acute diarrhoea in national programs is therefore required. This study aimed to address this issue.

Conditions

  • Diarrhea
  • Mortality
  • Hospitalization

Interventions

  • Zinc and ORSDrug

    Government and private providers and village health workers were trained to prescribe zinc and ORS for use in diarrheal episodes in 1 month to 5 years old children in intervention communities

  • ORS onlyDrug

    Promoted routine management of diarrhea in underfive with ORS

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate in a community based controlled effectiveness trial whether addition of zinc as a therapeutic modality for diarrhea delivered through existing channels, including at village level to the current case management package for under-five childrenTime frame: 20 months (Jan 2005 to Sep 2006)
  2. - Reduction in visits to health care providers for treatment of illnessTime frame: 20 months (Jan 2005 to Sep 2006)
  3. - Reduction in drug use; antibiotics and other drugs during diarrheal illnessesTime frame: 20 months (Jan 2005 to Sep 2006)
  4. - Increase in ORS use during diarrhea in the intervention communities.Time frame: 20 months (Jan 2005 to Sep 2006)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Society for Applied Studies

    New Delhi, National Capital Territory of Delhi, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.